Afficher la notice abrégée

Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ)

dc.rights.licenseopenen_US
dc.contributor.authorSUNHARY DE VERVILLE, Pierre-Louis
dc.contributor.authorSTUBBS, Brendon
dc.contributor.authorETCHECOPAR-ETCHART, Damien
dc.contributor.authorGODIN, Ophélia
dc.contributor.authorANDRIEU-HALLER, Christelle
dc.contributor.authorBERNA, Fabrice
hal.structure.identifierInstitut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA]
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorAOUIZERATE, Bruno
dc.contributor.authorCAPDEVIELLE, Delphine
dc.contributor.authorCHEREAU, Isabelle
dc.contributor.authorCLAUSS-KOBAYASHI, Julie
dc.contributor.authorCOULON, Nathalie
dc.contributor.authorDOREY, Jean-Michel
dc.contributor.authorDUBERTRET, Caroline
dc.contributor.authorLEIGNIER, Sylvain
dc.contributor.authorMALLET, Jasmina
dc.contributor.authorMISDRAHI, David
dc.contributor.authorPASSERIEUX, Catherine
dc.contributor.authorPIGNON, Baptiste
dc.contributor.authorREY, Romain
dc.contributor.authorURBACH, Mathieu
dc.contributor.authorLLORCA, Pierre-Michel
dc.contributor.authorSCHÜRHOFF, Franck
dc.contributor.authorLANÇON, Christophe
dc.contributor.authorBOYER, Laurent
dc.contributor.authorFOND, Guillaume
dc.date.accessioned2024-09-09T08:09:18Z
dc.date.available2024-09-09T08:09:18Z
dc.date.issued2022-10-01
dc.identifier.issn1433-8491en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/201493
dc.description.abstractEnThe World Health Organization (WHO) recommends adults complete 150-300 min per week of moderate physical activity or 75-150 min of vigorous physical activity or an equivalent combination of both, to optimize health. To explore the factors associated with adequate MVPA in stabilized outpatients with schizophrenia. 425 stabilized outpatients were recruited in the national FACE-SZ cohort between 2015 and 2018 were evaluated with the International Physical Activity Questionnaire and a 1-day long standardized battery. We explored in multivariate analyses the clinical and pharmacological factors associated with MVPA (model 1) and the biological factors and patient-reported outcomes (model 2). Overall, only 86 (20.2%) of the 425 participants achieved the recommended MVPA threshold. In model 1, the adequate MVPA group was associated with younger age, mood stabilizers prescription and adherence to treatment, independent of sex, positive and depressive symptoms, first-generation antipsychotics prescription, anxiolytic medication, and akathisia. In model 2, adequate MVPA was associated with better glycemic and lipidic profile and better physical and psychological well-being, self-esteem, sentimental life, and resilience independently of age, sex, and current psychotic severity. The expert centers recommend the importance of promoting promote effective MVPA programs for stabilized patients with schizophrenia. Interventions studies suggest that MVPA may be a useful strategy to maximize physical and psychological well-being and self-esteem and potentially to prevent or manage metabolic disturbances.
dc.language.isoENen_US
dc.subject.enPsychiatry
dc.subject.enPublic health
dc.subject.enMental health
dc.subject.enSchizophrenia
dc.subject.enQuality of life
dc.subject.enFunctioning
dc.title.enRecommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ)
dc.title.alternativeEur Arch Psychiatry Clin Neuroscien_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1007/s00406-022-01384-xen_US
dc.identifier.pubmed35441901en_US
bordeaux.journalEuropean Archives of Psychiatry and Clinical Neuroscienceen_US
bordeaux.page1273-1282en_US
bordeaux.volume272en_US
bordeaux.hal.laboratoriesNutrition et neurobiologie intégréeen_US
bordeaux.issue7en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionBordeaux INPen_US
bordeaux.institutionINRAEen_US
bordeaux.institutionCNRS
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European%20Archives%20of%20Psychiatry%20and%20Clinical%20Neuroscience&rft.date=2022-10-01&rft.volume=272&rft.issue=7&rft.spage=1273-1282&rft.epage=1273-1282&rft.eissn=1433-8491&rft.issn=1433-8491&rft.au=SUNHARY%20DE%20VERVILLE,%20Pierre-Louis&STUBBS,%20Brendon&ETCHECOPAR-ETCHART,%20Damien&GODIN,%20Oph%C3%A9lia&ANDRIEU-HALLER,%20Christelle&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée